Skip to content

Clinical study on the application of lidong needling therapy based on the theory of meridian and tendon to assist in the treatment of rheumatoid arthritis

Clinical study on the application of lidong needling therapy based on the theory of meridian and tendon to assist in the treatment of rheumatoid arthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000568
Enrollment
Unknown
Registered
2025-03-22
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

Sponsors

Taizhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Meets the RA diagnostic criteria established by ACR/EULAR in 2010; 2. Individuals aged 18 to 75 regardless of gender; 3. Visual Analog Scale (VAS) = 30mm Disease activity score (DAS 28)>3.2 points; 4.Individuals who can take care of themselves express themselves clearly and cooperate with treatment examinations and relevant assessments; 5. Prior to recruitment receive stable doses of biomedical combination therapy for at least one month including Disease modifying anti rheumatic drugs (DMARDs) nonsteroidal anti-inflammatory drugs and corticosteroids (equal to or less than 15 mg/day of prednisone or equivalent) and be advised not to change conventional treatment methods during the study period; 6).Voluntarily participate in this experiment and sign the informed consent form..

Exclusion criteria

Exclusion criteria: 1. Severe subjects with severe joint deformities with joint function in stage IV or above; 2.Merge other rheumatic and immune system diseases (such as systemic lupus erythematosus Sjogren's syndrome ankylosing spondylitis etc.); 3.Patients with other serious diseases such as heart brain liver kidney or hematopoietic system; 4. Pregnant and lactating women; 5. Received acupuncture treatment for RA in the past 3 months; 6. Participate in other clinical studies within the past 3 months. Those who meet one or more of the above requirements will be excluded.1.

Design outcomes

Primary

MeasureTime frame
Week 8 DAS 28 Score;

Secondary

MeasureTime frame
DAS 28 score;Proportion of subjects achieving clinical remission (DAS 28 score = 2.6);Disease condition VAS score;Clinical observational index evaluation;Hand function assessment;Measurement of knee joint range of motion;The subject's evaluation of physical function;Acupuncture improves the quality of life of the subjects;Emotional state evaluation;

Countries

China

Contacts

Public ContactWang Zhijuan

Taizhou Traditional Chinese Medicine Hospital

757423234@qq.com18261062609

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026